Elevated High-Sensitivity Troponin and NT-proBNP Values in Febrile Children

被引:1
|
作者
Borensztajn, Dorine M. [1 ,2 ,6 ]
Tan, Chantal D. [1 ]
de Rijke, Yolanda [3 ]
Hagedoorn, Nienke N. [1 ]
Verbruggen, Sascha C. [4 ]
Moll, Henriette A. [1 ]
Vermont, Clementien L. [5 ]
机构
[1] Erasmus MC, Sophia Childrens Hosp, Dept Gen Pediat, Rotterdam, Netherlands
[2] Northwest Clin, Dept Pediat, Alkmaar, Netherlands
[3] Erasmus MC, Univ Med Ctr Rotterdam, Dept Clin Chem, Rotterdam, Netherlands
[4] Erasmus MC, Sophia Childrens Hosp, Dept Pediat & Pediat Surg, Intens Care Unit, Rotterdam, Netherlands
[5] Erasmus MC, Sophia Childrens Hosp, Dept Pediat Infect Dis & Immunol, Rotterdam, Netherlands
[6] Erasmus MC, Sophia Childrens Hosp, POB 2060, NL-3000 CB Rotterdam, Netherlands
关键词
multisystem inflammatory syndrome in children; fever; N-terminal probrain natriuretic peptide; high-sensitivity troponin; NATRIURETIC PEPTIDE BNP; DYSFUNCTION;
D O I
10.1097/PEC.0000000000003097
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: The COVID-19 pandemic and subsequent rise of multisystem inflammatory syndrome in children have raised interest in high-sensitivity troponin (hs-TnT) and N-terminal probrain natriuretic peptide (NT-proBNP) because these have been found to be elevated in many cases of multisystem inflammatory syndrome in children. Our aim was to study hs-TnT and NT-proBNP concentrations in febrile children not affected by COVID-19. Methods: We retrospectively measured cardiac markers, hs-TnT, and NT-proBNP in leftover blood samples of febrile children (0-18 years) diagnosed and treated in a single-center emergency department (ED) (N = 67) and pediatric intensive care unit (PICU) (N = 19) that participated in a multicenter, prospective study of infection biomarkers (PERFORM). Results: Concentrations of hs-TnT, median 1.8 ng/L (interquartile range [IQR], 0.0-15.1), and NT-proBNP, 194 pg/mL (IQR, 54.9-706), were higher in febrile children than in controls (N = 25, hs-TnT 0.0 [IQR, 0-0]; NT-proBNP 56.3 [IQR, 29.7-109], both P < 0.001), whereas PICU patients had higher concentrations (hs-TnT 15.1 [IQR, 10.3-102] and NT-proBNP 828 [IQR, 657-4712], both P < 0.001) than ED patients (hs-TnT 0 [IQR, 0-7.4] and NT-proBNP 104 [IQR, 39.5-363]). No differences were found between viral and bacterial infections. Highest concentrations were found in children with either comorbidity predisposing to elevated concentrations (eg, chronic cardiac or renal disease) or children with critical illness or multiorgan failure such as those with septic shock. Conclusions: Concentrations of hs-TnT and NT-proBNP are often elevated in febrile children with different causes of fever. Concentrations were higher in children admitted to the PICU than in children attending the ED, and seem to reflect disease severity rather than the underlying cause of fever.
引用
收藏
页码:108 / 113
页数:6
相关论文
共 50 条
  • [31] Variation of NT-proBNP and High-Sensitivity Cardiac Troponin T Across Levels of Estimated Glomerular Filtration Rate: The SPRINT Trial
    Bansal, Nisha
    Katz, Ronit
    Seliger, Stephen
    deFilippi, Christopher
    Wettersten, Nicholas
    de Lemos, James A.
    Christenson, Robert
    Killeen, Anthony A.
    Berry, Jarett D.
    Shlipak, Michael G.
    Ix, Joachim H.
    CIRCULATION, 2024, 149 (12) : 967 - 969
  • [32] Early elevated NT-proBNP but not troponin I is associated with severe bronchiolitis in infants
    Rodriguez-Gonzalez, Moises
    Estepa-Pedregosa, Lorena
    Estalella-Mendoza, Ana
    Castellano-Martinez, Ana
    Rodriguez-Campoy, Patricia
    Flores-Gonzalez, Jose Carlos
    CLINICA CHIMICA ACTA, 2021, 518 : 173 - 179
  • [33] Comparison of dilated cardiomyopathy patients with normal and elevated levels of NT-proBNP and troponin
    Dziewiecka, E.
    Winiarczyk, M.
    Gliniak, M.
    Kaciczak, M.
    Robak, J.
    Rubis, P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 105 - 105
  • [34] The concentration of high-sensitivity troponin I, galectin-3 and NT-proBNP substantially increase after a 60-km ultramarathon
    Salvagno, Gian Luca
    Schena, Federico
    Gelati, Matteo
    Danese, Elisa
    Cervellin, Gianfranco
    Guidi, Gian Cesare
    Lippi, Giuseppe
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (02) : 267 - 272
  • [35] Nt-proBNP and high sensitive troponin in Friedreich ataxia's cardiopathy
    Legrand, L.
    Maupain, C.
    Monin, M. L.
    Tataru, A.
    Komajda, M.
    Durr, A.
    Isnard, R.
    Pousset, F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 213 - 213
  • [36] Can the Addition of NT-proBNP and Glucose Measurements Improve the Prognostication of High-Sensitivity Cardiac Troponin Measurements for Patients with Suspected Acute Coronary Syndrome?
    Kavsak, Peter A.
    Mondoux, Shawn E.
    Hewitt, Mark K.
    Ainsworth, Craig
    Hill, Stephen
    Worster, Andrew
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2021, 8 (09)
  • [37] Elevated troponin and NT-ProBNP are associated with severe intraventricular haemorrhage in pre term infants
    Barry, D. J.
    El-Khuffash, A.
    Molloy, E. J.
    ACTA PAEDIATRICA, 2007, 96 : 17 - 18
  • [38] EFFECT OF TOCILIZUMAB ON CARDIAC BIOMARKERS HIGH-SENSITIVITY TROPONIN T AND NT-PROBNP IN RHEUMATOID ARTHRITIS: POST HOC ANALYSIS OF A RANDOMISED CONTROLLED TRIAL
    Welsh, P.
    Tuckwell, K.
    Sattar, N.
    ATHEROSCLEROSIS, 2016, 252 : E58 - E58
  • [39] Predictive Value of Baseline Serum High-Sensitivity Troponin I and NT-proBNP for Cardiac Immunotoxicity Risk During Immune Checkpoint Inhibitor Therapy
    Rao, Anjali
    Prasad, Tanushree
    Simon, Shayna
    Zhu, Hong
    Venkatesh, Vishnu
    Ali, Sadia
    Bermas, Bonnie
    Bernabela, Luigino
    Bhai, Salman
    Brugarolas, James
    Castillo, Pedro
    Chandra, Alvin
    Dao, Kathryn
    Mammen, Pradeep P.
    Garg, Sonia
    Homsi, Jade
    Oz, Orhan
    Ratti, Gregory
    Selby, Chris
    Vallabhaneni, Srilakshmi
    Zhang, Kathleen
    De Lemos, James A.
    Sweetenham, John
    Hammers, Hans
    Zaha, Vlad G.
    CIRCULATION, 2022, 146
  • [40] Urinary values of NT-proBNP in children with congenital heart disease - Is it feasible?
    Mueller, Nicole
    Rothkegel, Stefanie T.
    Boerter, Nicolas
    Breuer, Johannes
    Freudenthal, Noa J.
    CLINICA CHIMICA ACTA, 2020, 509 : 224 - 227